Feedback / Questions
MDNA113 - Medicenna
https://www.globenewswire.com/news-release/2025/04/30/3071395/0/en/Medicenna-Presents-Promising-Preclinical-Data-from-its-First-in-Class-Tumor-Targeted-and-Conditionally-Activated-Anti-PD-1-IL-2-Bifunctional-Superkine-at-the-Annual-2025-AACR-Meeti.html
Apr 30, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next